Akouos (AKUS) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $13.29
▼
$13.29
50-Day Range: $13.29
▼
$13.29
52-Week Range: $2.32
▼
$13.60

Volume: 440 shs
Average Volume: 344,411 shs
Market Capitalization: $490.88 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Source

Source	Headline
	William W. Backus Hospital health.usnews.com - May 17 at 11:25 PM
	Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer finance.yahoo.com - May 16 at 7:22 AM
	Acquisition Corp Kearny Purchases 29,992,668 Shares of Akouos, Inc. (NASDAQ:AKUS) Stock marketbeat.com - December 1 at 6:30 PM
	Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases finance.yahoo.com - December 1 at 6:28 PM
	marketbeat.com - December 1 at 6:04 AM
	Brokers Issue Forecasts for Akouos, Inc.'s FY2022 Earnings (NASDAQ:AKUS) marketbeat.com - November 17 at 8:58 AM
	Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights finance.yahoo.com - November 14 at 11:06 AM
	Short Interest in Akouos, Inc. (NASDAQ:AKUS) Drops By 63.4% marketbeat.com - November 11 at 3:08 AM
	Akouos (AKUS) Set to Announce Earnings on Thursday marketbeat.com - November 9 at 7:38 AM
	Akouos Target of Unusually Large Options Trading (NASDAQ:AKUS) marketbeat.com - October 24 at 10:50 AM
	Akouos, Inc. to Post Q3 2022 Earnings of ($0.66) Per Share, William Blair Forecasts (NASDAQ:AKUS) marketbeat.com - October 21 at 5:34 AM
	Akouos stock soars 87% as Lilly nabs hearing loss gene therapy developer - Seeking Alpha seekingalpha.com - October 19 at 3:28 AM
	AKUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akouos, Inc. Is Fair to Shareholders - Business Wire businesswire.com - October 18 at 10:19 PM
	Akouos (NASDAQ:AKUS) Lowered to Market Perform at William Blair marketbeat.com - October 18 at 8:22 PM
	Crude Oil Drops Over 2%; Akouos Shares Spike Higher - Akouos (NASDAQ:AKUS), ADS-TEC Energy (NASDAQ:ADSE) - Benzinga benzinga.com - October 18 at 5:18 PM
	Eli Lilly To Pay Up To $610M For Gene Therapy Biz Akouos - Law360 law360.com - October 18 at 5:18 PM
	Eli Lilly to buy genetic medicine developer Akouos for $487 million - Nasdaq nasdaq.com - October 18 at 12:00 PM
	2022-10-18 \| NDAQ:AKUS \| Press Release \| Akouos Inc. - Stockhouse stockhouse.com - October 18 at 12:00 PM
	Eli Lilly to Buy Akouos for Up to $610 Million >LLY AKUS - MarketWatch marketwatch.com - October 18 at 12:00 PM
	Akouos Shares Soar on Takeover by Eli Lilly >AKUS - MarketWatch marketwatch.com - October 18 at 12:00 PM
	Eli Lilly to acquire Akouos for up to about $610 million and develop gene therapies for hearing loss - MarketWatch marketwatch.com - October 18 at 12:00 PM
	Eli Lilly To Buy Akouos For Up To $610 Mln - Nasdaq nasdaq.com - October 18 at 12:00 PM
	Eli Lilly & Co. (LLY) Acquires Akouos (AKUS) for $610M - StreetInsider.com streetinsider.com - October 18 at 12:00 PM
	Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why - Nasdaq nasdaq.com - October 10 at 1:34 PM
	Akouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why finance.yahoo.com - October 10 at 1:34 PM
	AKUS stock rated Bullish at William Blair on gene therapy for hearing loss (NASDAQ:AKUS) - Seeking Alpha seekingalpha.com - September 29 at 8:09 PM
	Akouos Gains as William Blair Starts Coverage at Outperform - Marketscreener.com marketscreener.com - September 29 at 8:09 PM
	Akouos (NASDAQ:AKUS) Coverage Initiated at William Blair marketbeat.com - September 29 at 7:36 AM
	Arthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures - Yahoo Finance finance.yahoo.com - September 27 at 1:13 PM
	Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday By Benzinga - Investing.com UK uk.investing.com - September 14 at 9:06 AM
	Alcohol Justice to Participate at Alcohol Policy-19 Evidence to Action: Building a Framework for Change - Yahoo Finance finance.yahoo.com - September 14 at 4:06 AM
	FDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing Loss finance.yahoo.com - September 13 at 5:37 PM
	Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss finance.yahoo.com - September 13 at 12:37 PM
	Akouos Says FDA Clears IND Application For AK-OTOF For OTOF-mediated Hearing Loss markets.businessinsider.com - September 13 at 12:37 PM
	Akouos stock rises 11% on FDA clearance to start gene therapy trial for hearing loss - Seeking Alpha seekingalpha.com - September 13 at 7:36 AM
	Form SC 13G/A Akouos, Inc. Filed by: FEDERATED HERMES, INC. - StreetInsider.com streetinsider.com - September 9 at 6:57 PM
	Akouos, Inc. (AKUS) Upgraded to Buy: Here's Why - Nasdaq nasdaq.com - August 18 at 11:53 PM
	Akouos, Inc. (AKUS) Upgraded to Buy: Here's Why finance.yahoo.com - August 18 at 1:52 PM
	Akouos (NASDAQ:AKUS) Issues Earnings Results marketbeat.com - August 16 at 7:14 AM
	This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday - Benzinga benzinga.com - August 16 at 5:14 AM
	Akouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights - Yahoo Finance finance.yahoo.com - August 16 at 5:14 AM
	AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com marketscreener.com - August 15 at 10:44 AM
	Akouos: Q2 Earnings Insights - Benzinga benzinga.com - August 15 at 10:44 AM
	Akouos GAAP EPS of -$0.58 beats by $0.21 (NASDAQ:AKUS) - Seeking Alpha seekingalpha.com - August 15 at 10:44 AM
	Akouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights - GlobeNewswire globenewswire.com - August 15 at 10:44 AM
	AKOUOS, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.com marketscreener.com - July 26 at 8:03 PM
	GlycoEra AG Expands Board of Directors and Appoints Georges Gemayel, Ph.D., as Chair - PR Newswire prnewswire.com - July 12 at 8:58 AM
	Can You Pull Off Early Retirement, Despite the Recent Stock Market Downturn? - Nasdaq nasdaq.com - July 7 at 8:51 AM
	Pre-market Movers: EVTV, USEA, AKUS, GME, ANVS… - RTTNews rttnews.com - July 7 at 8:51 AM
	Akouos : Statement of Changes in Beneficial Ownership (Form 4) \| MarketScreener - Marketscreener.com marketscreener.com - June 29 at 11:06 PM

Get Akouos News Delivered to You Automatically

AKUS Media Mentions By Week

AKUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AKUS
News Sentiment
▼
0.00

0.86
▲
Average
Medical
News Sentiment

AKUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AKUS Articles
This Week
▼
0

0
▲
AKUS Articles
Average Week

Get Akouos News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:AKUS) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Akouos (AKUS) News Today

AKUS Media Mentions By Week

AKUS Media Sentiment

AKUS News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info